Establishing secure connection…Loading editor…Preparing document…

Concert Pharmaceuticals Inc Annual Reports

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

9.02(c) Guidelines for Invention ("Laboratory") Notebooks

[Note: The following procedures were developed to guide the preparation and maintenance of so-called "laboratory notebooks," which are often used to record the process of invention in a reliable way. This will permit an informed decision about whether to protect an invention as a trade secret or to seek a patent, and will provide a record of who contributed to the invention and when they did their work. If the decision is made to apply for a patent, the notebook might be used as evidence in any related litigation.]

I. Procedures

A. Type of Notebook

Inventors should use permanently bound notebooks-i.e., those having a closed spiral binding or a stiff cover, with the pages bound in permanently. Separate loose-leaf sheets or forms should be used only when it is absolutely necessary, and they should be permanently affixed to the next available page(s) in the bound notebook.

B. Tracking the Notebooks

If the notebooks are maintained as part of an organized research program, the lab should keep a catalogue listing all notebooks.

Each notebook should be assigned a number.

Before a notebook is distributed to a person, that person should complete a "request form" and a "receipt form." The "request form" identifies the person who is requesting a notebook. The person receiving the notebook executes a "receipt form" acknowledging that he or she has indeed received the notebook. Each recipient should be admonished that no one other than the recipient should write in a notebook "checked out" to the recipient.

A "distribution list" setting forth the recipient of each notebook, as well as the date the recipient received the notebook, should be maintained.

When the recipient is through with the notebook, the recipient should check it in. The date the recipient checks in the notebook should be recorded on the distribution list.

Similarly, when the recipient leaves the employment of the lab, all notebooks checked out to the recipient should be turned in.

All completed notebooks should be indexed, catalogued and maintained in a central, secure repository.

II. Contents of the Notebooks

A. Basic Mechanics

Entries should be made in ink, and in chronological order.

An entry should never be erased or "whited out." If an entry contains erroneous information, a line should be drawn through that information.

If an entire page is wrong, it should not be torn out; a few lines should be drawn through the page.

An entry made on a previous occasion should never be altered. If data were omitted, the data should be recorded under a new date and cross-referenced to the previous entry.

Blank gaps should never be left between entries. If blank space was left, a cross should be drawn over the blank space and dated so as to prevent subsequent entries.

Each notebook should be signed and dated on the inside front cover. The date is the date the recipient started using the notebook.

Each entry within the notebook should be signed and dated.

B. Contents of the Notebook Entries

(1) Conception of Invention

Legally, "conception" is the "formation in the mind of the inventor, of a definite and permanent idea of the complete and operative invention, as it is thereafter to be applied in practice." To establish conception of the invention, the following information should be recorded:

Name or title of the invention:

Intended purpose, objective or use of the invention:

Description of the invention, including sketches as appropriate:

Advantages of the invention over prior art, including all novel features:

Notebook entries showing conception of the invention should be signed and dated by the inventor. "Conception" is also subject to the independent corroboration rule. Accordingly, independent witnesses (i.e., persons other than co-inventors or those who performed the particular experiments) should also sign and date the record of conception.

(2) Reduction to Practice

Actual reduction to practice requires that the applicant prove that "the embodiment relied upon as evidence of priority actually worked for its intended purpose." Constructive reduction to practice occurs when a patent application on the claimed invention is filed. Reduction to practice is subject to the "rule of reason" standard. This rule requires the courts to "examine, analyze, and evaluate reasonably all pertinent evidence when weighing the credibility of the inventor's story." To record reduction to practice, the following types of entries may be useful:

Descriptions of tests, including preferred operating conditions, control conditions, operable and preferred ranges of conditions, and alternate specific materials

Test results as well as an explanation of the results. Conclusions regarding the results should be kept to a minimum, and be provided only if they are supported by factual data. Conclusions should be brief and objective.

Photos, sketches, output from laboratory equipment or computer programs, and other such material should be signed, dated, witnessed and affixed to the notebook in proper chronological order. The date the material is affixed to the notebook should be recorded as well. Once affixed to the notebook, this material should not be removed.

Date of reduction to practice:

Test description:

Test results and explanation:

C. Witnessing the Notebook

Notebook entries should be witnessed. The reason for this is that in patent priority disputes, the courts require that the inventor's testimony be independently corroborated even if supported by a properly completed notebook. The witnesses should be:

Skilled in the art. Witnesses who know of the experiments only generally cannot provide sufficient corroboration. The corroborating witness must be capable of understanding, and in fact have understood, how the claimed invention worked to produce the desired results.

Independent. Corroborating witnesses should not be those who performed the particular experiments. Co-inventors should not witness notebook entries.

The observations of the corroborating witnesses should be contemporaneous with the experiments, as well as with the consequent notebook entries. While one witness may be sufficient, two or more are preferred. This will increase the likelihood that at least one witness will be available in the event he or she must later testify.

Inventor name:

Inventor signature date:

Inventor signature:

Witness name:

Witness signature date:

Witness signature:

III. The Completed Invention

The notebooks recording conception and reduction to practice of an invention should be maintained in a safe place. Unless a priority contest arises, nothing more than that really needs to be done with the notebooks. However, they of course constitute a record of the process of, and investment in, research and development. As such, they can be useful in any dispute (for example, trade secret litigation) in which the company might want to reconstruct relevant research.

Enter text✕

What Concert Pharmaceuticals Inc Annual Reports are and how they are used

Concert Pharmaceuticals Inc Annual Reports are the company’s formal yearly disclosures to shareholders and regulators that combine narrative business discussion, audited financial statements, governance information and required regulatory filings (for a public company, typically the SEC Form 10-K and the annual report to shareholders). These reports summarize performance, material risks, management discussion and audited results, and may be distributed electronically to investors, posted on the company website, and filed with the SEC through EDGAR for public record and investor review.

Why a well-prepared annual report matters for Concert Pharmaceuticals Inc

A complete, accurate annual report meets SEC disclosure obligations, supports investor confidence, and documents corporate governance and financial performance. Electronic delivery and robust records preservation help demonstrate compliance with ESIGN (15 U.S.C. §7001) and state electronic transaction laws such as UETA where applicable.

Why a well-prepared annual report matters for Concert Pharmaceuticals Inc

Primary audiences and internal teams involved

Annual reports require coordination across finance, legal, investor relations, and executive leadership.

  • Investors and analysts who rely on audited financial statements and risk disclosures to evaluate company performance and outlook.
  • Corporate finance and accounting teams responsible for preparing audited schedules, footnotes, and reconciliations for the report.
  • Legal, compliance, and investor relations teams that review disclosures, manage SEC filing logistics, and communicate with stakeholders.

Core components every Concert Pharmaceuticals Inc Annual Report should include

A professional annual report combines narrative context and verified financials. Make sure each required element is present, consistently formatted, and cross-referenced to audited schedules.

Cover & Summary

Executive summary, letter to shareholders, fiscal year and contact information presented clearly for readers.

Management Discussion

Management’s Discussion and Analysis (MD&A) covering results, trends, liquidity, and forward-looking material.

Audited Financials

Balance sheet, income statement, cash flow and notes audited by an independent registered public accounting firm.

Risk Factors

Material risks affecting the business, including development, regulatory, market, and operational risks.

Corporate Governance

Board composition, committee reports, executive compensation disclosure, and related governance practices.

Exhibits & Certifications

Required SEC exhibits, CEO/CFO certifications, and auditor’s opinion or report appended as required.

Essential fields and required data elements

Company Name: Concert Pharmaceuticals Inc
Fiscal Year: Reporting period end date
Form Type: e.g., Form 10-K or annual report
Management Discussion: MD&A narrative included
Financial Statements: Audited balance sheet and notes
Auditor Report: Independent auditor’s opinion

Step-by-step: preparing and finalizing the annual report

Follow these sequential steps to assemble, review and sign the annual report before SEC submission and investor distribution.

  • 01
    Compile Materials: Gather audited statements, MD&A, governance disclosures and exhibits.
  • 02
    Internal Review: Finance, legal and IR teams review for completeness and accuracy.
  • 03
    Executive Signoff: Authorized officers sign certifications and attestations.
  • 04
    File and Distribute: File with SEC (EDGAR) and distribute to shareholders as required.

Where to send, file, and publish Concert Pharmaceuticals Inc Annual Reports

Use official and secure channels for filing, and maintain controlled distribution lists for investor delivery and public posting.

  • SEC Filing: Submit required forms to EDGAR for public record and regulatory compliance.
  • Investor Distribution: Provide electronic copies to shareholders and registrars per proxy rules.
  • Company Website: Post the annual report in an investor relations section for public access.
  • Internal Records: Retain master signed copies in corporate records and compliance repositories.

Configuring a secure eSignature workflow for annual report approval

Set up a clear approval route with required signer order, authentication strength, and audit capture to support regulatory review and evidence of consent.

Field Configuration
Signer Order Sequential approval: preparer → legal → CFO → CEO
Authentication Email + SMS code or stronger ID verification
Audit Trail Capture IP, timestamp, and signer events
Retention Store signed copy and certificate per retention policy

Technical considerations for eSubmission and secure sharing

Ensure the platform supports strong encryption, robust audit trails, and integrations you use for filings and archival.

  • Formats Supported: PDF, Word DOCX and spreadsheet attachments
  • Integrations: Connectors for NetSuite, Google Workspace, and Microsoft 365
  • Compliance: SOC 2, ISO 27001, and ESIGN/UETA support

eSignature vendor comparison for signing Concert Pharmaceuticals Inc Annual Reports

Compare common pricing and capability dimensions when selecting an eSignature provider for annual report workflows; signNow is listed first per comparison format.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Consequences of inaccurate or late annual reports

Late SEC Filing: Exchange sanctions or delisting risk
Regulatory Enforcement: SEC inquiries and possible penalties
Investor Lawsuits: Increased litigation exposure
Reputational Harm: Loss of investor confidence
Restatement: Material misstatement may require restatement
Audit Issues: Qualified opinion or audit delays

Common pitfalls when preparing Concert Pharmaceuticals Inc Annual Reports

  • Incomplete cross-references between MD&A and financial notes lead to reviewer confusion and potential SEC comment letters.
  • Using inconsistent company names or ticker symbols across schedules creates reconciliation problems for filing systems and auditors.
  • Failing to capture full signature and certificate metadata undermines audit trails and weakens proof of approval.
  • Delaying external auditor engagement or final reviews increases the risk of missed deadlines and costly extensions.

Key filing timelines and typical deadlines for annual reporting

Timing depends on filer classification; plan backward from statutory deadlines to allow audits, internal review, and executive signoff.

Form 10-K Deadline:

Large accelerated filers: 60 days; accelerated filers: 75 days; others: 90 days

Proxy / Annual Meeting:

Proxy statements typically distributed in advance of the shareholder meeting per company bylaws

Auditor Completion:

Complete external audit well before SEC filing deadlines

Executive Certifications:

CEO/CFO sign certifications contemporaneous with filing

Record Retention Start:

Retention clock begins on creation or filing as applicable

How to update or amend an already-submitted annual report

If corrections are necessary, follow an amendment process that preserves the original filing history and provides clear disclosure of changes.

01

Identify Error:

Document the nature and scope of the inaccuracy
02

Assess Materiality:

Determine whether the change is material under SEC rules
03

Prepare Amendment:

Draft corrected pages and explanatory notes
04

Obtain Approvals:

Secure same signatory approvals as original filing
05

File Amendment:

Submit revised filing to EDGAR per amendment procedures
06

Notify Stakeholders:

Inform auditors, board, and key investors as appropriate

Examples: how organizations applied eSignature and digital workflows

These real-world examples show how electronic signing and integrated workflows helped large organizations streamline document approvals and maintain compliance.

Tech Data — Executive approvals

Tech Data centralized approvals and accelerated signoff for financial and customer documents.

  • They improved internal and external customer service while increasing speed to revenue.
  • Tech Data uses airSlate SignNow to improve our internal and external customer service while increasing our speed to revenue.

Xerox — Systems integration

Xerox connected signing workflows to NetSuite to automate recordkeeping and archives.

  • Integration reduced manual entry and ensured consistent document formats.
  • airSlate SignNow provides us with the flexibility needed to get the right signatures on the right documents, in the right formats, based on our integration with NetSuite.

Who typically has authority to sign Concert Pharmaceuticals Inc Annual Reports

Chief Executive Officer

The CEO often certifies that the report fairly presents the company’s financial condition and results; their signature carries governance and legal attestations required by securities rules.

Corporate Secretary

The corporate secretary frequently executes the filing on behalf of the corporation and ensures proper corporate approvals and recordkeeping for board minutes and resolutions.

FAQs and troubleshooting for Concert Pharmaceuticals Inc Annual Reports

Answers to common questions about preparing, signing, filing, and preserving annual reports for corporate and regulatory compliance.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users